webinar register page

Pharmaron's DMPK Webinar Series
July 26: Transporters

We will be taking a break for the month of Augusts, however, the webinar series will resume September 22 where we'll discuss enzyme induction.
Sep 22, 2022 09:00 AM
Oct 26, 2022 09:00 AM
Time shows in
Webinar logo
* Required information
Loading

Speakers

Prof Amin Rostami-Hodjegan, PharmD, Ph.D., FCP, FAAPS, FJSSX
Director, CAPKR @at University of Manchester
Amin is a Professor of Systems Pharmacology and the Director of the Centre for Applied Pharmacokinetic Research the University of Manchester. In addition, he is the Senior Vice President of Research & Development and Chief Scientific Officer at Certara. Over the last 30 years his scientific work covers wide areas of drug development ranging from pharmaceutics to clinical pharmacology and beyond. He is a leader in the field of physiologically-based pharmacokinetics and quantitative systems pharmacology, and is internationally recognized for his work to understand and predict drug behavior in the human body. He facilitates the incorporation of the latest advances in translational modelling to biosimulation platforms offered by Certara to accelerate regulatory approvals and bring safer drug products to the patients faster.
Michael Hall, PhD
Manager, in vitro and DDI @Pharmaron
After completing his PhD studies at the Department of Biochemistry, University College London in 1984, Michael moved to the Institute of Cancer Research in London as a postdoctoral research fellow. There he investigated the stereochemistry of the metabolic activation of polycyclic aromatic hydrocarbons. Through it, he gained familiarity with the area of xenobiotic metabolising enzymes and drug metabolism generally. In 1988 Michael moved to Huntingdon Research Centre (now a part of Labcorp), where he specialised in in vitro techniques applied to DMPK studies. He became the inaugural Head of the Department of In Vitro Metabolism in 1998, and Head of In Vitro Metabolism and Biotransformation in 2012. Michael left Huntingdon in 2013 and joined Quotient Bioresearch Ltd. (now Pharmaron UK), firstly as Business Development Manager for the company’s In Vitro Services and, in November 2014 as Head of the In Vitro and DDI Services group.
Jia Jia, PhD
Associate Director, ADMET @Pharmaron
Dr. Jia joined Pharmaron in 2018 and is the associate director of the in vitro ADME department in Ningbo. She is leading an experienced team that supports sponsors for early screening ADME assays. She manages the progress of projects, provides scientific input to optimize assay systems and ensures high quality data submission in a time efficient way. Dr. Jia received her M.S. degree in cell and molecular biology from the University of Hannover, Germany in 2007 and her Ph.D degree in the area of drug transporters from the clinical pharmacology institute at the University of Greifwald, Germany in 2013. Her research was focused on transporter studies using in vitro and in vivo models. Jia then worked for 4.5 years at a biotech company in Germany primarily working on metabolic stability and DDI assays using liver microsomes and hepatocytes.